Biblio
“Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1117-1127, 2020.
, “An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1085-1103, 2020.
, “Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.
, “Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 863-881, 2020.
, “Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1281-1296, 2020.
, “Flickering Red-Light Stimulus for Promoting Coherent 40 Hz Neural Oscillation: A Feasibility Study.”, J Alzheimers Dis, vol. 75, no. 3, pp. 911-921, 2020.
, “From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1271-1283, 2020.
, “Functional Connectivity Alterations of the Temporal Lobe and Hippocampus in Semantic Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1461-1475, 2020.
, “Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology is Associated with Absence of Synaptic Tau Oligomers.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1661-1678, 2020.
, “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Gamma Entrainment in a Large Retrospective Cohort: Implications for Photic Stimulation Therapy for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1181-1190, 2020.
, “Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1417-1435, 2020.
, “Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein.”, J Alzheimers Dis, vol. 75, no. 1, pp. 45-60, 2020.
, “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.
, “The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1541-1554, 2020.
, “Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1215-1242, 2020.
, “An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1639-1653, 2020.
, “The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 573-585, 2020.
, “Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 1, pp. 247-257, 2020.
, “In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.”, J Alzheimers Dis, vol. 73, no. 1, pp. 147-161, 2020.
, “Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia.”, J Alzheimers Dis, vol. 74, no. 2, pp. 435-439, 2020.
, “Inflammation in Traumatic Brain Injury.”, J Alzheimers Dis, vol. 74, no. 1, pp. 1-28, 2020.
, “Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
, “Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1201-1209, 2020.
, “lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 1, pp. 85-98, 2020.
,